Scott Bizily, Chief Legal Officer: 4D Molecular Therapeutics FDMT Planned sale · Filed 25/09/23

Trade details

Type: Planned sale notice
Stock: 4D Molecular Therapeutics FDMT
Person: Scott BizilyChief Legal Officer
Planned sale date: 25/09/23
Filed: 25/09/23

$54.1K to be sold

4D Molecular Therapeutics trades, last 26 weeks

What else happened in 4D Molecular Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/24~25/10/23

Scott Bizily's recent trades

Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$79.7K
6,540 sh
$79.7K
Filed 08/17
Traded 08/17
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$19.4K
1,635 sh
$19.4K
Filed 08/13
Traded 08/13
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$84.6K
6,566 sh
$84.6K
Filed 06/30
Traded 06/30
Scott BizilyChief Legal Officer
Sell10b5-1 plan4D Molecular Therapeutics
Sell10b5-1 plan
4D Molecular Therapeutics
FDMT
$117.7K
9,810 sh
$117.7K
Filed 06/25
Traded 06/23
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$102.2K
9,810 sh
$102.2K
Filed 06/23
Traded 06/23

Scott Bizily, CLO — plans to sell 7,312 sh of 4D Molecular Therapeutics FDMT · $54.1K · around 09/23 · 10b5-1 plan | Whalegun